Fact CheckerSign in

NCT04711057Completed

CENTR(AR): Lungs Moving

Source: ClinicalTrials.gov · Last updated 19 Jan 2024

Brief summary (registry, in English)

Chronic Respiratory Diseases (CRDs) are associated with substantial morbidity and mortality, ranking as the third leading cause of death worldwide. Pulmonary rehabilitation (PR) is a fundamental evidence-based intervention for the management of a variety of CRDs, such as Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Diseases (ILDs). However, the benefits of PR tend to decline over time and there is currently no strong evidence that patients translate those benefits into a more active lifestyle. There is an urgent need for evidence-based interventions to promote physical activity (PA) participation, whilst maintaining PR positive effects in the long-term. Community-based PA interventions adjusted to the local context, as well as patients' needs and preferences, might be a key strategy to meet this target. CENTR(AR) will be a sustainable response to support healthy lifestyles and enhance long-term PR benefits, by providing access to PR within Primary Healthcare Centres (PHC), followed by the inclusion in a community-based PA program, which embraces urban facilities and available resources.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
13 Jan 2021
Start date
1 Apr 2021
Primary completion date
1 Jun 2023
Lead sponsor
Aveiro University
Diseases
COPD
NCT number
NCT04711057

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Apr 2021 to the primary completion date, 1 Jun 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Signs of cognitive impairment;
  • Neoplasic/Immunologic disease or an unstable/significant cardiac (e.g., exertional angina, valvular heart disease, congestive heart failure, etc.), musculoskeletal/orthopaedic, neuromuscular or psychiatric condition limiting ability to exercise or co-operate.

Who the study is looking for

  • Clinical diagnosis of a chronic respiratory disease;
  • Stable clinical condition (defined as no acute exacerbation or hospitalization in the previous month).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
School of Health Sciences of the University of Aveiro (ESSUA)
Coordinator of this site? Confirm its status
AveiroPortugalUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.